Drugs Index
Medical Conditions:
- Medical Conditions G
- Medical Conditions I
- Medical Conditions P
- Medical Conditions C
- Medical Conditions N
- Medical Conditions T
- Medical Conditions E
- Medical Conditions D
- Medical Conditions F
- Medical Conditions H
- Medical Conditions M
- Medical Conditions B
- Medical Conditions U
- Medical Conditions O
- Medical Conditions S
- Medical Conditions A
- Medical Conditions R
- Medical Conditions L
- Medical Conditions W
- Medical Conditions V
- Medical Conditions K
- Medical Conditions J
- Medical Conditions X
Drug Classes
- Drug Classes A
- Drug Classes M
- Drug Classes H
- Drug Classes C
- Drug Classes B
- Drug Classes U
- Drug Classes T
- Drug Classes O
- Drug Classes I
- Drug Classes N
- Drug Classes V
- Drug Classes E
- Drug Classes G
- Drug Classes P
- Drug Classes L
- Drug Classes Q
- Drug Classes F
- Drug Classes S
- Drug Classes D
- Drug Classes R
- Drug Classes 5
- Drug Classes K
Drugs Information:
Drugs List
1. Name Of The Medicinal Product
QUINODERM CREAM 5
2. Qualitative And Quantitative Composition
Benzoyl Peroxide BP 5.0%
Potassium Hydroxyquinoline Sulphate BP 0.5%
3. Pharmaceutical Form
Quinoderm Cream 5 is a creamy white astringent vanishing cream.
It is intended for topical use only.
4. Clinical Particulars
4.1 Therapeutic Indications
Acne vulgaris, acneform eruptions, folliculitis.
4.2 Posology And Method Of Administration
Route of administration
For topical use only.
Adults, children and the elderly:
By gentle massage over all the affected area two or three times daily.
4.3 Contraindications
Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream 5.
4.4 Special Warnings And Precautions For Use
Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely dye fastness.
In a few isolated cases, overreaction to Quinoderm Cream 5 may occur. To minimise this possibility, select a small area of skin behind the ear, apply the cream and leave for twelve hours. If severe irritation or pronounced redness occurs, do not proceed with treatment.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
Benzoyl Peroxide is an oxidising agent. Hence, Quinoderm Cream 5 should not be used at the same time as other topical agents which would react with an oxidising agent.
4.6 Pregnancy And Lactation
Quinoderm Cream 5 is not contra-indicated in pregnancy or lactation.
1. Name Of The Medicinal Product
QUINOPED™ CREAM2. Qualitative And Quantitative Composition
|
Benzoyl Peroxide BP |
5.0% |
|
Potassium Hydroxyquinoline Sulphate BP |
0.5% |
3. Pharmaceutical Form
Quinoped Cream is a cream-coloured astringent cream.
4. Clinical Particulars
4.1 Therapeutic Indications
Quinoped Cream is indicated in the treatment of tinea pedis (athlete's foot) and other related fungal infections.
4.2 Posology And Method Of Administration
Route of administration: For topical use only.
Adults, children and the elderly: Spread thinly over all the affected area and gently massage until no trace of the cream can be seen on the skin surface. Apply morning and night.
4.3 Contraindications
Known sensitivity to either of the active ingredients. Quinoped Cream is for topical use only.
4.4 Special Warnings And Precautions For Use
Care should be taken to avoid contact with dyed fabrics as this preparation may adversely affect dye fastness. In a few isolated cases overreaction to Quinoped Cream may occur. To avoid this possibility select a small area of skin on the feet, apply the cream and leave for twelve hours. If severe irritation or pronounced redness occurs do not proceed.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
Benzoyl Peroxide is an oxidising agent. Hence Quinoped Cream should not be used at the
1. Name Of The Medicinal Product
Quinapril/Hydrochlorothiazide 10/12.5 mg film-coated tablets
2. Qualitative And Quantitative Composition
10/12.5 mg:
Each film-coated tablet contains 10 mg of quinapril equivalent to 10.83 mg of quinapril hydrochloride and 12.5 mg hydrochlorothiazide.
Excipient: Each film-coated tablet contains 18.45 mg of lactose (as lactose monohydrate).
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Film-coated tablet.
10mg/12.5mg:
Pink coloured, scored, oval shaped, biconvex, film-coated tablets debossed with 'D' on scored side and '18' on other side.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
4. Clinical Particulars
4.1 Therapeutic Indications
Quinapril/Hydrochlorothiazide is indicated as substitution therapy only in adult patients with essential hypertension already adequately controlled with quinapril and hydrochlorothiazide given concurrently.
4.2 Posology And Method Of Administration
Posology
Patients receiving quinapril and hydrochlorothiazide from separate tablets may be switched to combination tablets of Quinapril/Hydrochlorothiazide containing the same component doses.
Adults:
The recommended dose of Quinapril/Hydrochlorothiazide is one tablet per day.
Renal impairment
Due to hydrochlorothiazide component, Quinapril/Hydrochlorothiazide is contraindicated in patients with severe renal impairment (creatinine clearance <
1. Name Of The Medicinal Product
Quetiapine 150 mg Film-coated Tablets
2. Qualitative And Quantitative Composition
Each film-coated tablet contains 150 mg (as quetiapine hemifumarate).
Excipient (s):
Each 150 mg film-coated tablet contains 79.800 mg lactose monohydrate.
For a full list of excipients, see section 6.1
3. Pharmaceutical Form
Film-coated tablet
25mg tablets are pink coloured, round, biconvex, film-coated tablet, plain on both sides.
4. Clinical Particulars
4.1 Therapeutic Indications
Quetiapine tablet is indicated for the treatment of:
• Schizophrenia.
• Bipolar disorder, including:
|
|
• moderate to severe manic episodes in bipolar disorder |
|
|
• major depressive episodes in bipolar disorder |
|
|
• prevention of recurrence in patients whose manic or depressive episode has responded to quetiapine treatment. |
4.2 Posology And Method Of Administration
Quetiapine tablets can be administered, with or without food.
1. Name Of The Medicinal Product
Qvar 50 Autohaler 50 micrograms per actuation pressurised inhalation solution.
2. Qualitative And Quantitative Composition
Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.
(The dose delivered from the mouthpiece is an average 37.5 micrograms).
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.
Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs).
4. Clinical Particulars
4.1 Therapeutic Indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology And Method Of Administration
Qvar is for inhalation use only.
Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.
NOTE: The recommended total daily dose of Qvar is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.
To be effective, inhaled Qvar must be used on a regular basis even when patients are asymptomatic.
1. Name Of The Medicinal Product
Quetiapine 300 mg Film-coated Tablets
2. Qualitative And Quantitative Composition
Each film-coated tablet contains 300 mg (as quetiapine hemifumarate).
Excipient (s):
Each 300 mg film-coated tablet contains 159.600 mg lactose monohydrate.
For a full list of excipients, see section 6.1
3. Pharmaceutical Form
Film-coated tablet
300mg tablets are white to off white, capsule shaped, biconvex, film-coated tablet, with '300' debossed on one side and plain on other side.
4. Clinical Particulars
4.1 Therapeutic Indications
Quetiapine tablet is indicated for the treatment of:
o Schizophrenia.
o Bipolar disorder, including:
• moderate to severe manic episodes in bipolar disorder
• major depressive episodes in bipolar disorder
• prevention of recurrence in patients whose manic or depressive episode has responded to quetiapine treatment.
4.2 Posology And Method Of Administration
Quetiapine tablets can be administered, with or without food.
Adults
For the treatment of schizophrenia: Quetiapine tablets should be administered twice a daily. The total daily dose for the first 4 days of therapy is 50 mg (Day 1), 100 mg (Day 2), 200 mg (Day 3) and 300 mg (Day 4).
From day 4 onwards, the dose should be titrated to the usual effective dose range of 300 to 450 mg/day. Depending on the clinical response and tolerability of the individual patient, the dose may be adjusted within the range 150 to 750 mg/day.
For the treatment of moderate to se
1. Name Of The Medicinal Product
Quinoderm 5% / 0.5% w/w Cream
2. Qualitative And Quantitative Composition
|
Benzoyl Peroxide, hydrous |
5.0% w/w |
|
Potassium Hydroxyquinoline Sulphate |
0.5% w/w |
Excipients: Also includes cetostearyl alcohol, approx 0.825% w/w
For full list of excipients, see section 6.1
3. Pharmaceutical Form
Quinoderm Cream is a creamy white astringent vanishing cream. It is intended for topical use only.
4. Clinical Particulars
4.1 Therapeutic Indications
Acne vulgaris, acneform eruptions, folliculitis.
4.2 Posology And Method Of Administration
Route of administration
For topical use only.
Adults, children and the elderly
By gentle massage over all the affected area two or three times daily.
4.3 Contraindications
Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream.
4.4 Special Warnings And Precautions For Use
Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.
In a few isolated cases, overreaction to Quinoderm Cream may occur. To minimise this possibility,
1. Name Of The Medicinal Product
Quinine Bisulphate Tablets 300mg
2. Qualitative And Quantitative Composition
Quinine Bisulphate 300.00 mg BP
3. Pharmaceutical Form
Coated tablet
4. Clinical Particulars
4.1 Therapeutic Indications
The treatment of:- chloroquine-resistant malaria. Treatment and prevention of nocturnal leg cramps in adults and the elderly, when cramps cause regular disruption of sleep (see section 4.2 and Section 4.4)
4.2 Posology And Method Of Administration
Route of administration: Oral
For malaria:
Adults: in the treatment of chloroquine-resistant malaria - 600mg at 8 hourly intervals for 7 days.
Children: 10mg per kg bodyweight at 8 hourly intervals for 7 days
For the treatment and prevention of nocturnal leg cramps:
Adults (including elderly):
The recommended dose is 300mg at bedtime.
A reduction in frequency of leg cramps may take up to 4 weeks to become apparent. Patients should be monitored closely during the early stages of treatment for adverse effects. After an initial trial of 4 weeks, treatment should be stopped if there is no benefit. Treatment should be interrupted at approximately three monthly intervals to reassess the benefit of treatment.
Children: Not recommended
4.3 Contraindications
In patients with a history of hypersensitivity to quinine or any of the excipients in the tablet. In the presence of haemoglobinuria during malaria. Optic neuritis.
Tinnitus
Myasthenia gravis.
4.4 Special Warnings And Precautions For Use
Use with caution in pat
1. Name Of The Medicinal Product
Qvar 100 Autohaler 100 micrograms per actuation pressurised inhalation solution.
2. Qualitative And Quantitative Composition
Beclometasone Dipropionate 100 micrograms per metered (ex-valve) dose.
(The dose delivered from the mouthpiece is an average 75 micrograms).
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.
Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs).
4. Clinical Particulars
4.1 Therapeutic Indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology And Method Of Administration
Qvar is for oral inhalation use only
Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.
NOTE: The recommended total daily dose of Qvar is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.
To be effective, inhaled Qvar must be used on a regular basis even when patients are asymptomatic.
1. Name Of The Medicinal Product
Quetiapine 200 mg Film-coated Tablets
2. Qualitative And Quantitative Composition
Each film-coated tablet contains 200 mg (as quetiapine hemifumarate).
Excipient (s):
Each 200 mg film-coated tablet contains 106.400 mg lactose monohydrate.
For a full list of excipients, see section 6.1
3. Pharmaceutical Form
Film-coated tablet
200mg tablets are white to off white, round, biconvex, film-coated tablet, plain on both sides.
4. Clinical Particulars
4.1 Therapeutic Indications
Quetiapine tablet is indicated for the treatment of:
• Schizophrenia.
• Bipolar disorder, including:
|
|
• moderate to severe manic episodes in bipolar disorder |
|
|
• major depressive episodes in bipolar disorder |
|
|
• prevention of recurrence in patients whose manic or depressive episode has responded to quetiapine treatment. |
4.2 Posology And Method Of Administration
Quetiapine tablets can be administered, with or without food.
Adults
For the treatment of schizophrenia: Quetiapine t
1. Name Of The Medicinal Product
Qvar Easi-Breathe 100 micrograms per actuation pressurised inhalation solution
2. Qualitative And Quantitative Composition
Beclometasone Dipropionate 100 micrograms per metered (ex-valve) dose.
(The dose delivered from the mouthpiece is an average 75 micrograms).
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.
Qvar Easi-Breathe contains a propellant, which does not contain any chlorofluorocarbons (CFCs).
4. Clinical Particulars
4.1 Therapeutic Indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology And Method Of Administration
Qvar Easi-Breathe is for inhalation use only.
Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.
NOTE: The recommended total daily dose of Qvar Easi-Breathe is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.
To be effective inhaled Qvar Easi-Breathe must be used on a regular basis eve
1. Name Of The Medicinal Product
Quinoderm 5% / 0.5% w/w Cream
2. Qualitative And Quantitative Composition
|
Benzoyl Peroxide, hydrous |
5.0% w/w |
|
Potassium Hydroxyquinoline Sulphate |
0.5% w/w |
Excipients: Also includes cetostearyl alcohol, approx 0.825% w/w
For full list of excipients, see section 6.1
3. Pharmaceutical Form
Quinoderm Cream is a creamy white astringent vanishing cream. It is intended for topical use only.
4. Clinical Particulars
4.1 Therapeutic Indications
Acne vulgaris, acneform eruptions, folliculitis.
4.2 Posology And Method Of Administration
Route of administration
For topical use only.
Adults, children and the elderly
By gentle massage over all the affected area two or three times daily.
4.3 Contraindications
Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream.
4.4 Special Warnings And Precautions For Use
Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.
In a few isolated cases, overreaction to Quinoderm Cream may occur. To minimise this possibility,
1. Name Of The Medicinal Product
Quinoderm 10% / 0.5% w/w Cream
2. Qualitative And Quantitative Composition
|
Benzoyl Peroxide, hydrous |
10.0% w/w |
|
Potassium Hydroxyquinoline Sulphate |
0.5% w/w |
Excipients: Also includes cetostearyl alcohol, approx 0.825% w/w
For full list of excipients, see section 6.1
3. Pharmaceutical Form
Quinoderm Cream is a creamy white astringent vanishing cream. It is intended for topical use only.
4. Clinical Particulars
4.1 Therapeutic Indications
Acne vulgaris, acneform eruptions, folliculitis.
4.2 Posology And Method Of Administration
Route of administration
For topical use only.
Adults, children and the elderly
By gentle massage over all the affected area two or three times daily.
4.3 Contraindications
Acne rosacea. Patients with known sensitivity to either of the active ingredients should not use Quinoderm Cream.
4.4 Special Warnings And Precautions For Use
Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.
In a few isolated cases, overreaction to Quinoderm Cream may occur. To minimise this possibility
1. Name Of The Medicinal Product
Qvar 50 Aerosol 50 micrograms per actuation pressurised inhalation solution
2. Qualitative And Quantitative Composition
Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.
(The dose delivered from the mouthpiece is an average 37.5 micrograms).
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.
Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs).
4. Clinical Particulars
4.1 Therapeutic Indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology And Method Of Administration
Qvar is for inhalation use only.
Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.
NOTE: The recommended total daily dose of Qvar is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.
To be effective, inhaled Qvar must be used on a regular basis even when patients are asymptomatic.
TH
1. Name Of The Medicinal Product
Qvar Easi-Breathe 50 micrograms per actuation pressurised inhalation solution
2. Qualitative And Quantitative Composition
Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.
(The dose delivered from the mouthpiece is an average 37.5 micrograms).
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.
Qvar Easi-Breathe contains a propellant, which does not contain any chlorofluorocarbons (CFCs).
4. Clinical Particulars
4.1 Therapeutic Indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology And Method Of Administration
Qvar Easi-Breathe is for inhalation use only.
Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.
NOTE: The recommended total daily dose of Qvar Easi-Breathe is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.
To be effective, inhaled Qvar Easi-Breathe must be used on a regular basis ev
1. Name Of The Medicinal Product
Qvar 100 Aerosol 100 micrograms per actuation pressurised inhalation solution
2. Qualitative And Quantitative Composition
Beclometasone Dipropionate 100 micrograms per metered (ex-valve) dose.
(The dose delivered from the mouthpiece is an average 75 micrograms).
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator.
Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs).
4. Clinical Particulars
4.1 Therapeutic Indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology And Method Of Administration
Qvar is for inhalation use only.
Patients should be instructed in the proper use of their inhaler, including rinsing out their mouth with water after use. Patients should be advised that Qvar may have a different taste and feel than a CFC inhaler.
NOTE: The recommended total daily dose of Qvar is lower than that for current beclometasone dipropionate CFC containing products and should be adjusted to the needs of the individual patient.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise pulmonary function as soon as possible. When patients' symptoms remain under satisfactory control, the dose should be titrated to the lowest dose at which effective control of asthma is maintained.
To be effective inhaled Qvar must be used on a regular basis even when patients are asymptomatic.
TH
1. Name Of The Medicinal Product
QUINOCORT™ CREAM2. Qualitative And Quantitative Composition
|
Potassium Hydroxyquinoline Sulphate BP |
0.5% |
|
Hydrocortisone BP |
1.0% |
3. Pharmaceutical Form
Quinocort Cream is a faintly yellow vanishing cream. It is intended for topical use only.
4. Clinical Particulars
4.1 Therapeutic Indications
The treatment of infected eczema, intertrigo and other steroid-responsive dermatoses where anti-infective cover is appropriate.
4.2 Posology And Method Of Administration
Route of administration: For topical use only.
Adults, children and the elderly
By gentle massage over all the affected area two to three times daily.
4.3 Contraindications
Patients with known sensitivity or intolerance to any of the ingredients.
4.4 Special Warnings And Precautions For Use
Contact with eyes and other mucosal surfaces should be avoided. Caution should be exercised when using this preparation in infants. Long term continuous topical therapy should be avoided in infants - adrenal suppression can occur even without occlusion.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
Not applicable.
4.6 Pregnancy And Lactation
In pregnant animals administration of corticosteroids can cause abnormalities of foetal development. The relevance o
1. Name Of The Medicinal Product
QUINODERM™ LOTIO-GEL 5%2. Qualitative And Quantitative Composition
|
Benzoyl Peroxide BP |
5.0% |
|
Potassium Hydroxyquinoline Sulphate BP |
0.5% |
3. Pharmaceutical Form
Quinoderm Lotio-gel 5% is a homogeneous astringent gel formulated to give the colour and consistency of a creamy white lotion. It is intended for topical use only.
4. Clinical Particulars
4.1 Therapeutic Indications
Acne4.2 Posology And Method Of Administration
Route of administration: For topical use only.
Adults, children and the elderly
By gentle massage over all the affected area one to three times daily.
4.3 Contraindications
Patients with known sensitivity to either of the active constituents should not use Quinoderm Lotio-gel 5%.
4.4 Special Warnings And Precautions For Use
Contact with mouth and eyes should be avoided. Care should be taken to avoid contact with dyed fabrics as this product may adversely affect dye fastness.
In a few isolated cases, overreaction to Quinoderm Lotio-gel 5% may occur. To minimise this possibility, select a small area of skin behind the ear, apply the cream and leave for twelve hours. If severe irritation or pronounced redness occurs, do not proceed with treatment.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
Benzoyl peroxide is an oxidi
1. Name Of The Medicinal Product
Questran Light
2. Qualitative And Quantitative Composition
Each sachet contains 4g anhydrous colestyramine (a basic anion-exchange resin).
3. Pharmaceutical Form
Powder for Oral administration.
4. Clinical Particulars
4.1 Therapeutic Indications
Questran is used for:
|
1. |
Primary prevention of coronary heart disease in men between 35 and 59 years of age and with primary hypercholesterolaemia who have not responded to diet and other appropriate measures. |
|
2. |
Reduction of plasma cholesterol in hypercholesterolaemia, particularly in those patients who have been diagnosed as Fredrickson's Type II (high plasma cholesterol with normal or slightly elevated triglycerides). |
|
3. |
Relief of pruritus associated with partial biliary obstruction and primary biliary cirrhosis. |
|
4. |
Relief of diarrhoea associated with ileal resection, Crohn's disease, vagotomy and diabetic vagal neuropathy. |
|
5. |
1. Name Of The Medicinal Product
Hydroxychloroquine Sulphate 200 mg Film – Coated Tablets
Quinoric 200mg Film-Coated Tablets
2. Qualitative And Quantitative Composition
Each film-coated tablet contains 200 mg Hydroxychloroquine Sulphate B.P.
For a full list of excipients, see section 6.1
3. Pharmaceutical Form
Film coated tablet
White, circular, biconvex film coated tablets embossed with 'BL' on one face and '200' on the other.
4. Clinical Particulars
4.1 Therapeutic Indications
Treatment of rheumatoid arthritis, juvenile chronic arthritis, discoid and systemic lupus erythematosus, and dermatological conditions caused or aggravated by sunlight.
4.2 Posology And Method Of Administration
Adults (including the elderly)
The minimum effective dose should be employed. This dose should not exceed 6.5 mg/kg/day (calculated from ideal body weight and not actual body weight) and will be either 200 mg or 400 mg per day.
In patients able to receive 400mg daily:
Initially 400 mg daily in divided doses. The dose can be reduced to 200 mg when no further improvement is evident. The maintenance dose should be increased to 400 mg daily if the response lessens.
Children
The minimum effective dose should be employed and should not exceed 6.5 mg/kg/day based on ideal body weight. The 200 mg tablet is therefore not suitable for use in children with an ideal body weight of less than 31kg.
Each dose should be taken with a meal or glass of milk.
Hydroxychloroquine is cumulative in action and will requi